Jolene Wiltz v. HHS - Tdap, Guillain-Barré syndrome (2024)

Filed 2022-01-31Decided 2024-03-04Vaccine Tdap
compensated$136,000

Case summary [AI summaries can sometimes make mistakes]

On January 31, 2022, Jolene Wiltz filed a petition under the National Vaccine Injury Compensation Program alleging that she suffered from Guillain-Barré syndrome (GBS) as a result of a Tdap vaccination received on March 9, 2021. The respondent, the Secretary of Health and Human Services, denied that the vaccine caused Ms.

Wiltz's GBS or any other injury, and denied that her condition was a sequela of a vaccine-related injury. Despite maintaining these positions, both parties agreed to settle the case.

Special Master Katherine E. Oler reviewed the file and adopted the parties' stipulation as her decision.

The stipulation awarded Ms. Wiltz a lump sum of $136,000.00, payable by check, as compensation for all damages available under the program.

The decision was issued on March 4, 2024, approving the award and directing the Clerk of the Court to enter judgment. Petitioner's counsel was Glen Sturtevant, Jr. of Rawls Law Group.

Respondent's counsel was Meghan Murphy of the U.S. Department of Justice.

The public decision does not describe the onset of symptoms, specific clinical details, diagnostic tests, treatments, or expert witnesses.

Theory of causation

Petitioner Jolene Wiltz alleged that a Tdap vaccination received on March 9, 2021, caused her Guillain-Barré syndrome (GBS). The respondent denied causation. The parties entered into a joint stipulation to settle the case, with the respondent maintaining its denial of causation. The stipulation awarded Petitioner $136,000.00 in a lump sum. Special Master Katherine E. Oler adopted the stipulation as her decision. The public decision does not specify the theory of causation, the mechanism of injury, or name any experts.

Source PDFs 2 total · 1 downloaded